Press Releases

The Foundation for the National Institutes of Health (FNIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the National Institutes of Health (NIH), are announcing today a new partnership to investigate links across serious common diseases that researchers believe may share the same biological causes.

New guidance from the World Health Organization (WHO) sets essential standards to inform future research and development on genetically modified mosquitoes, particularly in addressing issues relating to ethics, safety, affordability and effectiveness.

The Foundation for the Institutes of Health (FNIH) has launched the Deeda Blair Research Initiative for Disorders of the Brain to drive innovation in mental health research.

Music has long been considered therapeutic for a number of brain disorders in the aging population, such as Parkinson’s disease and Alzheimer’s disease, and additional scientific data will help support ongoing research into the beneficial effects of music-based interventions (MBIs) for health.

The Foundation for the National Institutes of Health (FNIH) today bestowed its annual Trailblazer Prize for Clinician-Scientists to Michael Wilson, M.D., of the University of California San Francisco (UCSF).

The Foundation for the National Institutes of Health (FNIH) is honored to announce Anthony S. Fauci, M.D., as the recipient of the 2020 Charles A. Sanders, M.D., Partnership Award.

North Bethesda, MD, September 15, 2020 – The Foundation for the National Institutes of Health (FNIH) and the National Institute of Mental Health (NIMH), a part of the National Institutes of Health (NIH), announce the Accelerating Medicines Partnership in Schizophrenia (AMP SCZ), the first neuropsychiatric project of the landmark Accelerating Medicines Partnership (AMP) program managed by the FNIH.

FNIH on Twitter